Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia [EARLY_Phase 1]
This clinical trial is an early-phase study evaluating CD19 CAR NK cells for treating refractory primary immune thrombocytopenia (alloimmune…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
A Spanish registry (RESTI) for Primary Immune Thrombocytopenia and other immune thrombocytopenias is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP [Phase 2, Phase 3]
Clinical trial evaluating different cycles of high-dose dexamethasone in immune thrombocytopenia (ITP); currently not recruiting.
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
This study update describes the establishment of a biological bank and current recruitment for patients with autoimmune cytopenias at a refe…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia [Phase 2]
Open, exploratory Phase 2 clinical trial evaluating CM336 for treatment of immune thrombocytopenia is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of Herombopag for senile primary immune thrombocytopenia and is currently rec…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia [Phase 2]
A Phase 2, single-arm, open-label trial to evaluate zanubrutinib for immune thrombocytopenia is recruiting in China. The study is sponsored …
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies [Phase 2]
Phase 2 clinical trial update describing avatrombopag for adults with immune thrombocytopenia with autoantibodies, currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating avatrombopag for treatment of pediatric immune thrombocytopenia. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years [NA]
Clinical trial update for a thrombopoietin receptor agonist (TPO-RA) in immune thrombocytopenia in patients aged 14 years and older; the stu…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP) [Phase 2]
This is a Phase 2, prospective, single-arm trial evaluating obinutuzumab for pediatric immune thrombocytopenia, currently recruiting in Chin…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
This ClinicalTrials.gov entry notes a study evaluating immune status before and after splenectomy in patients with immune thrombocytopenia. …
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia [Phase 2]
Phase 2 prospective, one-arm open trial evaluating obinutuzumab for immune thrombocytopenia, currently recruiting in China.
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia. [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating eltrombopag as first-line therapy for Primary Immune Thrombocytopenia; the study is currently recru…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia [NA]
A clinical trial is evaluating mesenchymal stem cell therapy for patients with refractory primary immune thrombocytopenia. The study is curr…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure [NA]
Clinical trial comparing Ripertamab plus eltrombopag versus eltrombopag alone in patients with immune thrombocytopenia after failure of ster…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial is evaluating BCMA-CD19 CCAR T cell therapy for refractory immune thrombocytopenia associated with autoimmune disea…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP [Phase 2]
Phase 2 study evaluating the combination of glucocorticoids, gamma globulin, and Ropristine N01 for initial severe primary immune thrombocyt…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Longitudinal Cohort of Thrombosis and Hemostasis Diseases
A longitudinal cohort clinical trial in China studying thrombosis and hemostasis diseases. It is currently recruiting at Peking University P…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia [NA]
Clinical trial update examining whether acute phase proteins can aid in diagnosing immune thrombocytopenia. The study NCT06715215 is current…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP [Phase 2]
A Phase 2 clinical trial is evaluating romiplostim as a first-line treatment for newly diagnosed adults with Primary Immune Thrombocytopenia…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
This clinical trial update describes a prospective evaluation of diagnosis and treatment among patients with autoimmune cytopenias, includin…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy [Phase 2]
A Phase 2 trial evaluating prednisone alone versus prednisone plus intravenous immunoglobulin for immune thrombocytopenia during pregnancy i…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids [NA]
This clinical trial update notes an ongoing pediatric study evaluating thrombopoietin receptor agonists for persistent or chronic immune thr…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Observatory of Immunological Thrombopenic Purpura in the Brest Region
A recruiting ClinicalTrials.gov study in Brest investigating immune thrombocytopenia (immune thrombocytopenia/ITP).